Unnecessary thyroid nodule biopsy rates under four ultrasound risk stratification systems: a systematic review and meta-analysis

PH Kim, CH Suh, JH Baek, SR Chung, YJ Choi… - European …, 2021 - Springer
Objectives To summarize and compare unnecessary biopsy rates and diagnostic
performance in the examination of thyroid nodules according to four representative US …

Trends in thyroid cancer incidence and mortality in the United States, 1974-2013

H Lim, SS Devesa, JA Sosa, D Check, CM Kitahara - Jama, 2017 - jamanetwork.com
Importance Thyroid cancer incidence has increased substantially in the United States over
the last 4 decades, driven largely by increases in papillary thyroid cancer. It is unclear …

Thyroid cancer surgery guidelines in an era of de-escalation

KJ Kovatch, CW Hoban, AG Shuman - European Journal of Surgical …, 2018 - Elsevier
Well-differentiated thyroid carcinoma has seen a tremendous rise in global incidence over
the past three decades, largely owing to widespread screening and identification of small …

Diagnostic performance of practice guidelines for thyroid nodules: thyroid nodule size versus biopsy rates

SM Ha, JH Baek, DG Na, CH Suh, SR Chung, YJ Choi… - Radiology, 2019 - pubs.rsna.org
Background The diagnostic performance and unnecessary biopsy rates for evaluation of
thyroid nodules varies among the current society guidelines. We hypothesized that …

[HTML][HTML] Nomogram for predicting central lymph node metastasis in papillary thyroid cancer: a retrospective cohort study of two clinical centers

Z Yang, Y Heng, J Lin, C Lu, D Yu… - Cancer Research and …, 2020 - synapse.koreamed.org
Purpose Central lymph node metastasis (CNM) are highly prevalent but hard to detect
preoperatively in papillary thyroid carcinoma (PTC) patients, while the significance of …

BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment

Y Huang, S Qu, G Zhu, F Wang, R Liu… - JNCI: Journal of the …, 2018 - academic.oup.com
Background Precise risk stratification-based treatment of solitary intrathyroidal papillary
thyroid cancer (SI-PTC) that is larger than 1.0 cm and 4.0 cm or less is undefined. Methods A …

Insurance-based disparities in guideline-concordant thyroid cancer care in the era of de-escalation

SP Ginzberg, JMS Ballester, CJ Wirtalla… - Journal of Surgical …, 2023 - Elsevier
Introduction Prior studies have demonstrated insurance-based disparities in the treatment of
well-differentiated thyroid cancer. However, it remains unclear whether these disparities …

Selected controversies of radioiodine imaging and therapy in differentiated thyroid cancer

D Van Nostrand - Endocrinology and Metabolism Clinics, 2017 - endo.theclinics.com
Radioiodine is important in the diagnostic and therapeutic armamentarium of differentiated
thyroid cancer (DTC); however, many controversies persist. This article addresses some of …

European experience with the Afirma Gene Expression Classifier for indeterminate thyroid nodules: A clinical utility study in the Netherlands

I Lončar, EFS van Velsen, ET Massolt… - Head & …, 2023 - Wiley Online Library
Abstract Background The Gene Expression Classifier (GEC) and Genomic Sequencing
Classifier (GSC) were developed to improve risk stratification of indeterminate nodules. Our …

Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer

S Suh, YH Kim, TS Goh, J Lee, DC Jeong, SO Oh… - Endocrine, 2017 - Springer
Background Several staging systems have been developed to predict the risk of mortality in
patients with differentiated thyroid cancer (DTC). However, none of them have been shown …